Friday, August 19, 2022 11:38:54 AM
You and I already understand long haul covid at least in part. Folks fighting long haul covid19 are indoors, often in bed, taking dangerous pain killers like Ibuprofen day after day, that leads to Capillary Leakage of hemoglobin and Fenton's reagent Iron in the hemoglobin sets off catalytic inflation that does more damage and stimulates the Immune system...causing more inflammation and pain...
As a result the Vit D-3 levels drop, making things worse. The Glutathione levels drop, and the Liver gets sidetracked, and low D-3 causes depression IMO....from what all I have read...
And that is just for starters... IMO, Long Haul Covid is going to be a Bucci $RVVTF gold mine, and will help 100's of Millions of people world wide..... Now that we know so much more about how it works and important its action can be for fighting these chronic diseases....
And why would the FDA approve it for use in an orphan drug trial while this Covid19 trial is underway.
Also note that we learned a week ago, that NAC was used in a cancer chemo drug trial, and 50% of the NAC patients got a lot better on the chemo, and zero showed the improvements in the Placebo groups.
What it Bucci was tried next?
We already know one of the key things Bucci does, is 16 times more active than NAC at doing the same thing mg-Bucci/mg-NAC per dose.... And the NAC at 4X higher does is not tolerated by the digestive system...
We are sitting on a gold mine here, and only a fool rushes the path through the FDA trials...
As a result the Vit D-3 levels drop, making things worse. The Glutathione levels drop, and the Liver gets sidetracked, and low D-3 causes depression IMO....from what all I have read...
And that is just for starters... IMO, Long Haul Covid is going to be a Bucci $RVVTF gold mine, and will help 100's of Millions of people world wide..... Now that we know so much more about how it works and important its action can be for fighting these chronic diseases....
And why would the FDA approve it for use in an orphan drug trial while this Covid19 trial is underway.
Also note that we learned a week ago, that NAC was used in a cancer chemo drug trial, and 50% of the NAC patients got a lot better on the chemo, and zero showed the improvements in the Placebo groups.
What it Bucci was tried next?
We already know one of the key things Bucci does, is 16 times more active than NAC at doing the same thing mg-Bucci/mg-NAC per dose.... And the NAC at 4X higher does is not tolerated by the digestive system...
We are sitting on a gold mine here, and only a fool rushes the path through the FDA trials...
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
